# Florbetapir Calibration to the Centiloid Scale

> **NCT02120664** · PHASE1 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 35 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Florbetapir (18F)
- **DRUG:** 11C-PiB

## Key facts

- **NCT ID:** NCT02120664
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120664, "Florbetapir Calibration to the Centiloid Scale". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02120664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*